Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Initial results with a new trifocal diffractive hydrophobic IOL

Poster Details

First Author: R. Lapid-Gortzak NETHERLANDS

Co Author(s):    J. van der Linden   C. Nieuwendaal   I. van der Meulen   A. Abulafia           

Abstract Details

Purpose:

To report the initial results with implantation of a trifocal IOL. This trifocal IOL has a correction for distance at 40 and 60 cm.

Setting:

Retina Total Eye Care, private refractive surgery clinic, Driebergen, the Netherlands. Dept. of Ophthalmology, AMC, Amsterdam, University of Amsterdam, NL

Methods:

Prospective case series of 26 eyes (13 patients) implanted between July 4th 2015 and September 30th 2015 with the TFNT00 PanOptix trifocal IOL (Alcon, Fort Worth, USA) were prospectively followed. Outcome measures at 3 months were uncorrected distance acuity (UDVA)and corrected distance acuity (CDVA), patient preferred uncorrected near acuity (UNA), and monocular and binocular defocus curves, as well as mean spherical equivalent refraction (SE). Patient satisfaction, incidence of halos, and side effects were recorded.

Results:

The mean UDVA and CDVA at 3 months was -0.02 + 0.09 logMAR (0.1 to -0.18) and -0.05 + 0.07 (0.1 to -0.18) respectively. Patient preferred uncorrected near acuity was logMAR 0 in all patients. Mean postoperative SE was 0.06D + 0.26 (0.5D to -0.5D). The defocus curves showed a logMAR acuity of above 0.1 between +1D and -3D in the curve. Halos occurred in 3 patients. In 2 patients 1 eye was treated with a YAG capsulotomy at 3 months, with improved visual acuity and resolution of halos. All but 1 patient were satisfied (92.3%).

Conclusions:

The new trifocal IOL effectively corrects vision for distance, near and intermediate vision. Side effects may include halos due to increased sensitivity to posterior capsular folds and fibrosis. More study is needed to assess the behavior of the lens in clinical practice.

Financial Disclosure:

NONE

Back to Poster listing